Norman Schwartz
Norman Schwartz is number 66 in the 311 Private Wealth Index, with disclosed holdings in listed companies worth about $2.2bn, mainly in Bio-Rad Laboratories. That is about 11,456 times the wealth of a typical US household. Norman Schwartz is the chairman and chief executive officer and a 10% owner of Bio-Rad Laboratories.
Part of the 311 Private Wealth Index (311institute.com). Last updated .
Disclosed holdings
| Company | Value | Latest filing | Shares |
|---|---|---|---|
| Bio-Rad Laboratories | $2.2bn | 9 September 2026 | 7,988,336 at $276.36 |
How this figure is calculated
Shares reported in SEC insider filings (Forms 3, 4 and 5), at the latest holding each filing reports, valued at the latest price disclosed in those filings, or at the latest closing price where no recent trade price was filed. Holdings that the filings say belong to investment funds managed by the person are left out, and shares reported jointly by several family members are counted once. Private companies, cash, property and holdings listed outside the United States are not included, so this is a minimum, not total wealth. The household comparison uses $192,700, the median US household wealth in the Federal Reserve Survey of Consumer Finances (2022, the latest published).
Related
- Bio-Rad Laboratories in the 311 Titans Index
- Innovation profile of Hercules
- United States: economy and key statistics
- The 311 Private Wealth Index
- The 311 Titans Index
- All 311 Indexes
Questions and answers
What is Norman Schwartz's net worth?
Norman Schwartz has disclosed holdings in listed companies worth about $2.2bn, according to the 311 Private Wealth Index. This is a minimum: private companies, cash and property are not included.
How much are Norman Schwartz's disclosed holdings worth?
About $2.2bn in listed companies, ranking Norman Schwartz number 66 in the 311 Private Wealth Index.
Where does Norman Schwartz's wealth come from?
Mainly from holdings in Bio-Rad Laboratories. Norman Schwartz is the chairman and chief executive officer and a 10% owner of Bio-Rad Laboratories.
Source: SEC insider filings.
© 311 Institute 2026. Facts from official filings and the sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.